+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of drug treatment of primary alcoholism



Evaluation of drug treatment of primary alcoholism



La Revue du Praticien 49(4): 400-402



Clinical improvement (abstinence and sobriety) can be obtained in 30% of alcohol dependent (primary) patients at one year when therapy consists of meetings and talking with physicians. The association of drugs led to 40% clinical improvement in controlled studies. These drugs are acamprosate (Aotal), which is well tolerated and shown to be beneficial at one year, naltrexone (Revia), also well tolerated with a follow-up of 3 months, and lithium (Téralithe), to be used more cautiously, with a follow-up of one year. Disulfirame (Espéral), is poorly effective in its usual oral prescription, but is useful when prescribed with the assistance of a close relation. The authors propose an individual drug approach to each patient, with assessment of results at a set date.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046009373

Download citation: RISBibTeXText

PMID: 10319691


Related references

An evaluation of the SMAST questionnaire for the diagnosis of alcoholism in primary care. The Self-Administered Short Michigan Alcoholism Screening Test. Atencion Primaria 14(2): 627-630, 1994

Drug use among alcoholism detoxification patients prevalence and impact on alcoholism treatment. Alcoholism Clinical & Experimental Research 11(1): 95, 1987

Reliability data of a semistructured interview for the evaluation of alcoholism treatment the alcoholism severity index esa. Revista ABP-APAL (Associacao Brasileira de Psiquiatria-Asociacion Psiquiatrica de la America Latina) 10(1): 1-4, 1988

Metronidazole and alcoholism. (An evaluation of specific and non specific factors in drug treatment). Diseases of the Nervous System 31(9): 631-636, 1970

Alcoholism and other drug addictions: a primary disease entity. Journal of the Medical Association of Georgia 75(8): 490-494, 1986

The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study. Pharmacoeconomics 13(6): 719-730, 1998

The definition of alcoholism. The Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism. JAMA 268(8): 1012-1014, 1992

Alcoholism and other drug addictions: a primary disease entity, 1991 update. Journal of the Medical Association of Georgia 80(6): 337-342, 1991

Applications of primary human hepatocytes in the evaluation of pharmacokinetic drug-drug interactions: Evaluation of model drugs terfenadine and rifampin. Cell Biology and Toxicology 13(4-5): 365-374, 1997

Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction. Chemico Biological Interactions 107(1-2): 5-16, 1997

Review and evaluation of current drug therapies in alcoholism. International Journal of Psychiatry 3(4): 248-258, 1967

An evaluation of a symposium via satellite on alcoholism and drug dependence. Salud Publica de Mexico 35(5): 500-507, 1993

Chemical dependency treatment: the integration of the alcoholism and drug addiction/use treatment systems. International Journal of the Addictions 25(12a): 1515-1536, 1990